PDF Cover

Hypodermic Single Lumen Needles Market

Hypodermic Single Lumen Needles Market

The market for Hypodermic Single Lumen Needles was estimated at $2.6 billion in 2024; it is anticipated to increase to $4.1 billion by 2030, with projections indicating growth to around $5.9 billion by 2035.

Report ID:DS1801390
Author:Debadatta Patel - Senior Consultant
Published Date:July 2025
Datatree
Life Science
Medical Device
Hypodermic Single Lumen Needles
Share
Report Summary
Table of Contents
Methodology
Market Data

Global Hypodermic Single Lumen Needles Market Outlook

Revenue, 2024

$2.6B

Forecast, 2034

$5.5B

CAGR, 2024 - 2034

7.8%
The Hypodermic Single Lumen Needles industry revenue is expected to be around $2.8 billion in 2025 and expected to showcase growth with 7.8% CAGR between 2025 and 2034. The strong upward trend of the market for Hypodermic Single Lumen Needles showcases its increasing importance in the field of medicine. Numerous driving forces contribute to this growth such as the increasing occurrence of illnesses and an aging population worldwide along with advancements in medical technology. Moreover the continued significance of Hypodermic Single Lumen Needles in medical procedures and the growing need, for less invasive surgeries are key factors propelling the markets growth. Even during times like global health crises. the markets durability highlights how crucial Hypodermic Single Lumen Needles are, for healthcare providers.

Hypodermic Single Lumen Needles are known for their slender and hollow structure that enables the transfer of fluids into or out of the body. This of needles is essential in uses like giving vaccines and medicines or extracting blood samples. The increasing popularity of Hypodermic Single Lumen Needles is influenced by trends such as the growing interest in, at home healthcare allowing patients to manage their treatments with guidance.

Hypodermic Single Lumen Needles market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2024-2034

Market Key Insights

  • The Hypodermic Single Lumen Needles market is projected to grow from $2.6 billion in 2024 to $5.5 billion in 2034. This represents a CAGR of 7.8%, reflecting rising demand across Medical Diagnostics, Drug Administration and Anesthesia Delivery.
  • Becton Dickinson and Company, Medtronic Plc, Terumo Corporation are among the leading players in this market, shaping its competitive landscape.
  • U.S. and Germany are the top markets within the Hypodermic Single Lumen Needles market and are expected to observe the growth CAGR of 5.1% to 7.5% between 2024 and 2030.
  • Emerging markets including Brazil, Indonesia and South Africa are expected to observe highest growth with CAGR ranging between 9.0% to 10.8%.
  • Transition like Technological Advancements is expected to add $400.0 million to the Hypodermic Single Lumen Needles market growth by 2030
  • The Hypodermic Single Lumen Needles market is set to add $2.9 billion between 2024 and 2034, with manufacturer targeting Drug Administration & Fluid Administration Clinical Applications projected to gain a larger market share.
  • With Increasing prevalence of chronic diseases, and Technological advancements in needle design, Hypodermic Single Lumen Needles market to expand 112% between 2024 and 2034.
hypodermic single lumen needles market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032

Opportunities in the Hypodermic Single Lumen Needles

Collaborations between companies that make needles and healthcare providers can greatly enhance the market for Hypodermic Single Lumen Needles. There is an impact on improving the distribution and availability of these needles in hard to reach regions. Moreover tie ups with research organizations may result in enhancements and new features, in products thereby boosting market expansion.

Growth Opportunities in North America and Asia-Pacific

North America Outlook

In North America's healthcare sector sees growth in the market for Hypodermic Single Lumen Needles due to the regions top notch medical facilities and a high number of chronic illnesses prevalent here alongside increased healthcare spending. Leading manufacturers in this region heighten competition levels while advancements in technology and ongoing research offer avenues, for market growth. The main factor fueling this market is the increasing need, for invasive surgeries and procedures that heavily rely on Hypodermic Single Lumen Needles.

Asia-Pacific Outlook

The Asia Pacific region is becoming a market for Hypodermic Single Lumen Needles due to factors like a growing population and improved healthcare services leading to increased market demand despite facing tough competition from local manufacturers offering affordable options as the region sees a rise in lifestyle diseases and higher demand, for safe medical devices driving market growth here. The efforts made by governments to enhance healthcare facilities offer promising opportunities for the Hypodermic Single Lumen Needles market, in the Asia Pacific region.

Market Dynamics and Supply Chain

01

Driver: Increasing Prevalence of Chronic Diseases, and Growing Demand in Home Healthcare Settings

The increasing occurrence of long term illnesses globally plays a role in the Hypodermic Single Lumen Needles market sectors significance. These needles are also widely employed in managing ailments such as diabetes and heart disease. The growing prevalence of diseases calls for a higher demand for hypodermic single lumen needles, for medication administration purposes; hence contributing to market expansion. The growing trend of home healthcare, driven by the aging population and the need for cost-effective treatment outside hospitals, is also another key.Hypodermic single lumen needles are also vital for home-based care, particularly for patients requiring regular injections, thus fueling the market expansion.
The progress in needle design and technology has also resulted in creating less painful single lumen hypodermic needles that focus moreon enhancing patient comfort and reducing tissue damage the market is also moving forward due, to these advancements.
02

Restraint: Regulatory Compliance Challenges

The market for single lumen needles is encountering notable challenges because of strict regulatory guidelines and adherence criteria in place. These medical tools need to adhere to quality and safety benchmarks before gaining approval, for usage. Navigating the approval process can prove to be time intensive and costly affair which may potentially delay product introductions and affect market dynamics.
03

Opportunity: Technological Advancements and Expanding Healthcare Infrastructure

The introduction of advancements in the healthcare sector brings about a promising opportunity for Hypodermic Single Lumen Needles that have yet to be fully explored or utilized to their fullest potential! The improvements in needle construction and materials are anticipated to improve the comfort and safety of patients a factor that is likely to drive the increased use of these needles forward in healthcare settings worldwide! Moreover, the creation of needles with characteristics like reduced invasiveness and painlessness during injections is poised to generate a surge in demand, for them across medical settings.
The global expansion of healthcare infrastructure is anticipated to lead to an increase in the requirement for Hypodermic Single Lumen Needles in the coming years. Developing nations are making investments in healthcare amenities with a strong emphasis that will potentially enhance the demand for these needles; this focus mirrors their commitment to enhancing healthcare services through the integration of advanced medical instruments and equipment such, as Hypodermic Single Lumen Needles.
04

Challenge: Market Saturation

The hypodermic single lumen needles market is highly competitive, with numerous players offering similar products. This high level of competition can lead to market saturation, limiting the potential for growth and reducing the demand for new products. Furthermore, the presence of established players with strong brand recognition can make it difficult for new entrants to gain a foothold in the market.

Supply Chain Landscape

1
Raw Material Procurement

Thyssenkrupp AG

ArcelorMittal

2
Needle Production

Becton Dickinson and Company

Medtronic Plc

3
Distribution & Logistics

FedEx Corporation

DHL International GmbH

4
End Users

Hospitals

Clinics

Home Healthcare

*The illustration highlights the key stakeholders within the supply chain ecosystem.

Applications of Hypodermic Single Lumen Needles in Medical Diagnostics, Drug Administration & Anesthesia Delivery

Medical Diagnostics

Hypodermic Single Lumen Needles are extensively used in medical diagnostics for the collection of blood samples. The needles are designed to ensure minimal discomfort to the patient and to facilitate accurate sample collection. They are often used in conjunction with vacuum tubes for efficient and hygienic sample transfer. Top players in this field, such as Becton Dickinson and Company, have a strong market position due to their high-quality needles that prioritize patient comfort and safety.

Drug Administration

Hypodermic Single Lumen Needles are a key tool in the administration of various medications, including vaccines, insulin, and other injectable drugs. The needles are designed to deliver the medication intramuscularly, subcutaneously, or intravenously, depending on the specific requirements of the drug. Companies like Medtronic and Smiths Medical are leading the way in this application, with a focus on developing needles that minimize pain and tissue damage.

Anesthesia Delivery

Hypodermic Single Lumen Needles are also used in the delivery of anesthesia, particularly in regional anesthesia procedures such as epidurals and spinals. The needles are designed to deliver the anesthetic agent precisely to the desired location, ensuring effective pain management. Market leaders in this application include Teleflex Incorporated and Boston Scientific, known for their precision-engineered needles that enhance patient safety and procedural efficiency.

Recent Developments

December 2024

Becton Dickinson and Company launched a new range of Hypodermic Single Lumen Needles with enhanced safety features, aiming to reduce needlestick injuries among healthcare workers

November 2024

Medtronic PLC introduced its advanced Hypodermic Single Lumen Needles with improved sharpness and precision, targeting the growing demand in surgical procedures

October 2024

Terumo Corporation announced a significant expansion of its production capacity for Hypodermic Single Lumen Needles to meet the rising global demand.

The medical equipment industry witnessed a surge in demand for Hypodermic Single Lumen Needles, a key component in various medical procedures. These needles, known for their precision and efficiency, are increasingly being adopted in healthcare settings worldwide. The latest market trend indicates a growing preference for these needles due to their superior quality and performance.

Impact of Industry Transitions on the Hypodermic Single Lumen Needles Market

As a core segment of the Medical Device industry, the Hypodermic Single Lumen Needles market develops in line with broader industry shifts. Over recent years, transitions such as Technological Advancements and Shift Towards Safety Needles have redefined priorities across the Medical Device sector, influencing how the Hypodermic Single Lumen Needles market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Technological Advancements

The field of medicine has seen progress in the creation and usage of Hypodermic Single Lumen Needles with the development of needles featuring thin walls and finer bevel edges for enhanced patient comfort during injections. This shift towards needle technology has also influenced sectors like pharmaceutical companies by raising the need for top notch needles that are dependable, for drug administration purposes. This industry transition is expected to add $400 million in the industry revenue between 2024 and 2030.
02

Shift Towards Safety Needles

An increasing emphasis on safety within the healthcare sector has led to a transition towards the use of safety Hypodermic Single Lumen Needles. These needles are designed to prevent needlestick injuries, thereby reducing the risk of transmission of bloodborne pathogens. This transition has had a profound impact on the medical device manufacturing industry, spurring the development of innovative safety features and designs for hypodermic needles.

Related Reports

Loading related reports...